{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:25:43Z","timestamp":1785684343501,"version":"3.56.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pure and mixed desmoplastic melanomas (DMs) may have different natural histories and behaviors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a retrospective review of patients diagnosed with DM at our institution between January 1997 and April 2019. A total of 33 unique DMs were identified and subsequently analyzed based on the histologic type (pure vs. mixed).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The majority (57.6%) of our cases were classified as pure histology. Patients with pure DMs were more likely to be men (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.035) and be older than 65 years (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.019) compared with patients with mixed DMs. Patients with mixed DM were more likely to have mitoses present (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001) compared with patients with pure DM. There were no differences in ulceration, perineural invasion, vascular invasion, or survival between patients with pure and mixed histologic subtypes. In addition, no differences in sentinel lymph node biopsy, radiation, or chemotherapy were noted between the 2 histologic subtypes. Immunohistochemistry showed that 27.3% of the pure DMs stained with Melan-A and HMB45 were positive for these immunomarkers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Pure and mixed variants of DM were found to have similar clinicopathologic characteristics. Patients with the mixed histologic subtype were more likely to have mitoses, but no difference in the therapeutic management or patient survival was seen between the 2 subtypes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dad.0000000000001909","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T18:00:24Z","timestamp":1611770424000},"page":"776-780","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Pure and Mixed Desmoplastic Melanomas: A Retrospective Clinicopathologic Comparison of 33 Cases"],"prefix":"10.1097","volume":"43","author":[{"given":"Sherman","family":"Chu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, OH;"},{"name":"Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Northwest, Lebanon, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kory P.","family":"Schrom","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghav","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalynn R. Z.","family":"Conic","sequence":"additional","affiliation":[{"name":"Department of Family and Preventive Medicine, University of California San Diego, San Diego, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harib H.","family":"Ezaldein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, OH;"},{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, OH;"},{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH;"},{"name":"Department of Dermatology, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kord","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, OH;"},{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"330e","DOI":"10.1097\/PRS.0000000000002367","article-title":"Malignant melanoma: beyond the basics","volume":"138","author":"Pavri","year":"2016","journal-title":"Plast Reconstr Surg."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAP.0000000000000076","article-title":"Desmoplastic melanoma, neurotropism, and neurotrophin receptors\u2014what we know and what we do not","volume":"22","author":"Frydenlund","year":"2015","journal-title":"Adv Anat Pathol."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2012.10.041","article-title":"Desmoplastic melanoma: a review","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/COC.0b013e3182868e82","article-title":"Rare presentations of primary melanoma and special populations: a systematic review","volume":"37","author":"Kottschade","year":"2014","journal-title":"Am J Clin Oncol."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/CMR.0000000000000679","article-title":"Desmoplastic melanoma: an updated clinical review and the emerging role of genetic markers and immunotherapies","volume":"30","author":"Hadfield","year":"2020","journal-title":"Melanoma Res."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0560.2008.01058.x","article-title":"Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis","volume":"36","author":"George","year":"2009","journal-title":"J Cutan Pathol."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/01.pas.0000141391.91677.a4","article-title":"Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors","volume":"28","author":"Busam","year":"2004","journal-title":"Am J Surg Pathol."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/PAT.0b013e3283631c96","article-title":"Desmoplastic melanoma: recent advances and persisting challenges","volume":"45","author":"Wood","year":"2013","journal-title":"Pathology."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jso.25317","article-title":"Desmoplastic melanoma","volume":"119","author":"Nicolson","year":"2019","journal-title":"J Surg Oncol."},{"issue":"suppl 2","key":"R10-20250616","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/modpathol.3800516","article-title":"Unusual variants of malignant melanoma","volume":"19","author":"Magro","year":"2006","journal-title":"Mod Pathol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/SAP.0000000000001225","article-title":"Mixed versus pure variants of desmoplastic melanoma: the Cleveland clinic experience","volume":"80","author":"Conic","year":"2018","journal-title":"Ann Plast Surg."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"e0119716","DOI":"10.1371\/journal.pone.0119716","article-title":"Clinicopathologic predictors of survival in patients with desmoplastic melanoma","volume":"10","author":"Han","year":"2015","journal-title":"PLoS One."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/SLA.0b013e3181efc23c","article-title":"Pure desmoplastic melanoma: a melanoma with distinctive clinical behavior","volume":"252","author":"Maurichi","year":"2010","journal-title":"Ann Surg."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jamadermatol.2013.2248","article-title":"Clinical and dermoscopic characteristics of desmoplastic melanomas","volume":"149","author":"Jaimes","year":"2013","journal-title":"JAMA Dermatol."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/DAD.0b013e3181716e6b","article-title":"Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases","volume":"30","author":"de Almeida","year":"2008","journal-title":"Am J Dermatopathol."},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jso.21778","article-title":"Desmoplastic melanoma\u2014the step-child in the melanoma family?","volume":"103","author":"Wasif","year":"2011","journal-title":"J Surg Oncol."},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jamcollsurg.2013.05.006","article-title":"Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma","volume":"217","author":"Egger","year":"2013","journal-title":"J Am Coll Surg."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/cncr.25148","article-title":"Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients","volume":"116","author":"Murali","year":"2010","journal-title":"Cancer."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2133.2005.06462.x","article-title":"Desmoplastic malignant melanoma: a systematic review","volume":"152","author":"Lens","year":"2005","journal-title":"Br J Dermatol."},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ejso.2013.02.025","article-title":"Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy","volume":"39","author":"Broer","year":"2013","journal-title":"Eur J Surg Oncol."},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1245\/s10434-013-2883-z","article-title":"Desmoplastic melanoma: is there a role for sentinel lymph node biopsy?","volume":"20","author":"Han","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bjps.2016.11.003","article-title":"Is sentinel lymph node biopsy warranted for desmoplastic melanoma? A systematic review","volume":"70","author":"Dunne","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/cam4.2736","article-title":"Desmoplastic melanoma: the role of pure and mixed subtype in sentinel lymph node biopsy and survival","volume":"9","author":"Laeijendecker","year":"2020","journal-title":"Cancer Med."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","article-title":"Cutaneous melanoma, version 2.2019, NCCN clinical practice Guidelines in oncology","volume":"17","author":"Coit","year":"2019","journal-title":"J Natl Compr Canc Netw."},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature25187","article-title":"High response rate to PD-1 blockade in desmoplastic melanomas","volume":"553","author":"Eroglu","year":"2018","journal-title":"Nature."},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/1346-8138.13536","article-title":"Case of desmoplastic melanoma with lung metastasis maintaining complete response after cessation of nivolumab","volume":"44","author":"Murayama","year":"2017","journal-title":"J Dermatol."},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med."},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med."},{"key":"R29-20250616","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol."},{"key":"R30-20250616","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Correction to Lancet Oncol 2015; 16: 522. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:03:34Z","timestamp":1750100614000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001909","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,27]]}}}